Inventor
Heidi Alexandra Lane
Inventor
Therwil, CH
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes25%
G01NInvestigating or analysing materials by determining their chemical or physical properties21%
C07DHeterocyclic compounds17%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10%
PatentTitleYear
10,724,072Use of phospho-Akt as a biomarker of drug response202010,656,162Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles202010,487,075Substituted mono- and polyazanaphthalene derivatives and their use201910,222,377Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles201910,067,120Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles201810,006,078Use of phospho-Akt as a biomarker of drug response20189,995,754Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles20189,970,938Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles20189,476,889'Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles'20169,366,682'Use of stathmin as a biomarker of drug response to furazanobenzimidazoles'20168,877,771'Treatment of solid tumors with rapamycin derivatives'20148,778,962'Treatment of solid tumors with rapamycin derivatives'20148,436,010'Treatment of solid tumors with rapamycin derivatives'20138,410,131'Cancer treatment'20137,749,698'p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010Based in Biel-Benken, CH· patent location history
2013–2014Patents assigned to LANE HEIDI (4)· patent assignee history
2013–2014Patents assigned to NOVARTIS PHARMACEUTICALS CORP (4)· patent assignee history
2013–2019Based in Basel, CH· patent location history
2016–2020Patents assigned to BASILEA PHARMACEUTICA AG (9)· patent assignee history
2016–2019Patents assigned to BACHMANN FELIX (5)· patent assignee history
2016–2019Patents assigned to LANE HEIDI ALEXANDRA (5)· patent assignee history
2016–2020Based in Therwil, CH· patent location history
2018Based in Therwill, CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BASILEA PHARMACEUTICA AG | 9 | 2016–2020 |
| BACHMANN FELIX | 5 | 2016–2019 |
| LANE HEIDI ALEXANDRAself | 5 | 2016–2019 |
| LANE HEIDIself | 4 | 2013–2014 |
| NOVARTIS PHARMACEUTICALS CORP | 4 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Therwil, CH | 8 | 2016–2020 |
| Basel, CH | 5 | 2013–2019 |
| Therwill, CH | 1 | 2018 |
| Biel-Benken, CH | 1 | 2010 |